Trials / Unknown
UnknownNCT05235386
Clinical Impact of Automated Oxygen Administration on Confirmed or Suspected COVID-19 in the Emergency Department.
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 60 (estimated)
- Sponsor
- Laval University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this study is to evaluate the impact of the FreeO2 system on the quality of the oxygen therapy in confirmed or suspected SARS-CoV-2 patients in the emergency department.
Detailed description
The aim of this study is to evaluate the impact of the FreeO2 system on the quality of the oxygen therapy in confirmed or suspected SARS-CoV-2 patients in the emergency department. The quality of oxygen therapy is evaluated by the time spent in the SpO2 target (+/- 2% SpO2 target), time spent in hyperoxemia (\> 5% SpO2 target), time spent in hyperoxemia (\<5% SpO2 target).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Automated oxygen titration | Automated oxygen administration to maintain the SpO2 target at a predefined value during emergency length of stay |
Timeline
- Start date
- 2022-02-01
- Primary completion
- 2022-03-01
- Completion
- 2022-12-01
- First posted
- 2022-02-11
- Last updated
- 2022-02-11
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT05235386. Inclusion in this directory is not an endorsement.